PROTON NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY MEASUREMENTS OF METHYLENE AND METHYL LINE WIDTHS IN PLASMA - SIGNIFICANT VARIATIONS WITH EXTENT OF BREAST-CANCER, DURATION OF PREGNANCY AND AGING

被引:14
作者
ENGAN, T [1 ]
KRANE, J [1 ]
KVINNSLAND, S [1 ]
机构
[1] SINTEF,UNIMED,CTR NUCL MAGNET RESONANCE,TRONDHEIM,NORWAY
关键词
D O I
10.1002/nbm.1940040306
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The composite methylene (chemical shift range 1.2-1.4 ppm) and methyl (0.8-0.9 ppm) resonances of the H-1 NMR spectrum were analyzed in plasma samples from breast tumor patients, pregnant women, and healthy subjects. Using a 500 MHz NMR instrument operating at 25-degrees-C, the peaks were analyzed for line width at half height and then averaged. A statistically significant difference (p < 0.001) was found between the average (mean +/- SD) line width in the plasma samples from the 30 patients with metastatic breast cancer (34.1 +/- 5.0 Hz) and the controls matched for age and sex (38.7 +/- 4.4 Hz). In the 16 patients with localized breast cancer and the 16 with regional spread, the average line width was not different from that of matched controls. In 21 patients with benign tumor in the breast, the average line width was not different from that of matched controls. A difference in the average line width was found between 31 pregnant women in the third trimester (32.5 +/- 3.4 Hz) and their controls matched for age and sex (42.7 +/- 4.6 Hz) (p < 0.001). The average line width was lower in the late (31.5 +/- 3.3) than in the early (34.5 +/- 2.5 Hz) part of the third trimester (p = 0.022). In 54 healthy male and 130 healthy female controls, line widths declined gradually with increasing age by decades, except in the fifth decade for the men and the sixth decade for the women. The observations are consistent with an association between 'stage' in a most general sense and the apparent NMR lipid line widths, probably accounted for by a variation in plasma lipids.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 46 条
  • [1] ALEXOPOULOS CG, 1987, CANCER-AM CANCER SOC, V60, P3065, DOI 10.1002/1097-0142(19871215)60:12<3065::AID-CNCR2820601234>3.0.CO
  • [2] 2-Q
  • [3] BARCLAY M, 1970, CANCER RES, V30, P2420
  • [4] PLASMA AND BODY LIPIDS IN PATIENTS WITH CARCINOMA OF BREAST
    BASU, TK
    WILLIAMS, DC
    [J]. ONCOLOGY, 1975, 31 (3-4) : 172 - 176
  • [5] Bell J D, 1988, NMR Biomed, V1, P90, DOI 10.1002/nbm.1940010206
  • [6] H-1-NMR STUDIES OF HUMAN-BLOOD PLASMA ASSIGNMENT OF RESONANCES FOR LIPOPROTEINS
    BELL, JD
    SADLER, PJ
    MACLEOD, AF
    TURNER, PR
    LAVILLE, A
    [J]. FEBS LETTERS, 1987, 219 (01) : 239 - 243
  • [7] NMR-INVISIBLE LACTATE IN BLOOD-PLASMA
    BELL, JD
    BROWN, JCC
    KUBAL, G
    SADLER, PJ
    [J]. FEBS LETTERS, 1988, 235 (1-2) : 81 - 86
  • [8] DETECTION OF TUMORS WITH NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY OF PLASMA
    BERGER, S
    PFLUGER, KH
    ETZEL, WA
    FISCHER, J
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03): : 535 - 543
  • [9] BOCK JL, 1982, CLIN CHEM, V28, P1873
  • [10] BUCHTHAL SD, 1988, AM J MED, V85, P528